生物活性 | |||
---|---|---|---|
描述 | NCRW0005-F05 is a highly effective GPR139 antagonist, demonstrating an IC50 of 0.21 µM. It is applicable in studies concerning diabetes, obesity, and Parkinson's disease[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.46mL 0.69mL 0.35mL |
17.28mL 3.46mL 1.73mL |
34.57mL 6.91mL 3.46mL |
参考文献 |
---|